Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ENSG
ENSG logo

ENSG Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
171.110
Open
168.410
VWAP
169.64
Vol
785.89K
Mkt Cap
9.99B
Low
166.940
Amount
133.32M
EV/EBITDA(TTM)
16.22
Total Shares
58.45M
EV
9.30B
EV/OCF(TTM)
15.70
P/S(TTM)
1.87
The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at approximately 396 healthcare facilities in Alabama, Alaska, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. The Company's healthcare facilities include over 48 senior living operations across 17 states. The Company's segments include skilled services and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment consists of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. The Company's subsidiaries, including Standard Bearer, own approximately 181 real estate assets.
Show More

Events Timeline

(ET)
2026-07-02
06:30:00
Ensign Group Acquires Two Nursing Facilities in Texas
select
2026-06-11 (ET)
2026-06-11
16:30:00
Stocks Rebound as Retail Investors Submit Over $100B for SpaceX IPO
select
2026-06-11
14:00:00
Ensign Group Falls 4% After Muddy Waters Short Report
select
2026-06-11
14:00:00
Muddy Waters Short Ensign, Accuses of Fraud Scheme
select
link
2026-06-08 (ET)
2026-06-08
16:30:00
S&P and Nasdaq Bounce Back as Semiconductor Stocks Recover
select
2026-06-08
12:10:00
Major Averages Bounce Back, Oil Prices Rise
select
2026-06-02 (ET)
2026-06-02
06:10:00
Ensign Group Acquires Memory Care Facility in California
select
2026-05-13 (ET)
2026-05-13
10:00:00
CMS Implements Six-Month Moratorium on New Medicare Enrollment
select
link

News

Globenewswire
7.0
07-07Globenewswire
Ensign Group Under Investigation for Securities Fraud Claims
  • Securities Fraud Investigation: Pomerantz LLP is investigating whether Ensign Group and its executives have engaged in securities fraud or other unlawful business practices, indicating serious concerns regarding corporate governance and investor rights.
  • Short Report Allegations: On June 8, 2026, Hunterbrook published a short report accusing Ensign Group's business model of relying on inadequate patient care and manipulating quality metrics, which has reportedly led to patient harm and even deaths, directly impacting the company's reputation and investor confidence.
  • Significant Stock Drop: Following the Hunterbrook report, Ensign Group's stock price fell by $13.88, or 8.15%, closing at $156.42 per share, reflecting a pessimistic outlook from the market regarding the company's future prospects.
  • Medicare Fraud Claims: Muddy Waters Research published a report on June 11, 2026, alleging that Ensign Group may be involved in Medicare and Medicaid fraud by renting licenses of administrators who do not actually manage facilities, exacerbating investor concerns about compliance, leading to a further stock decline of $4.52, or 2.98%.
Globenewswire
7.0
07-06Globenewswire
Ensign Group Under Investigation for Securities Violations
  • Investigation Launched: Lowey Dannenberg P.C. is investigating The Ensign Group for potential violations of federal securities laws, including systemic quality data manipulation and falsified care quality data, leading to a significant stock price drop and millions in shareholder losses.
  • Impact of Short Seller Reports: On June 8, Hunterbrook published a short-seller report accusing Ensign of improper related-party billing in its skilled nursing operations, causing a notable decline in stock price and raising investor concerns about the company's transparency.
  • Allegations of Medicare Fraud: On June 11, Muddy Waters Research released a report alleging that Ensign may have engaged in Medicare and Medicaid fraud by renting licenses of administrators who do not actually manage the facilities, potentially violating the False Claims Act and intensifying market skepticism regarding its compliance.
  • Investor Losses: As a result of these events, shareholders of Ensign Group are facing significant financial losses, prompting Lowey Dannenberg to encourage affected investors to participate in the investigation to seek legal remedies and compensation.
PRnewswire
7.0
07-06PRnewswire
Investigation Launched into The Ensign Group's Securities Violations
  • Investigation Initiated: Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving The Ensign Group (NASDAQ:ENSG), emphasizing the importance of protecting investor rights and encouraging information sharing.
  • Stock Price Impact: Following a report from Muddy Waters Research on June 11, 2026, alleging deceptive practices at approximately 20% of Ensign's facilities, the company's stock price fell, indicating market concerns over its financial transparency and operational integrity.
  • Law Firm's Strength: Robbins Geller is a leading law firm in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone, showcasing its significant influence and success in the industry.
  • Historical Recovery Record: Over the past five years, Robbins Geller has recovered $8.4 billion for investors, including the largest securities class action recovery in history at $7.2 billion, highlighting its exceptional performance in safeguarding investor interests.
Newsfilter
7.0
07-06Newsfilter
Ensign Group Under Investigation for Potential Securities Law Violations
  • Investigation Launched: Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving The Ensign Group (NASDAQ:ENSG), and investors with relevant information can contact the firm through a provided link.
  • Report Uncovers Issues: On June 11, 2026, Muddy Waters Research published a report alleging that Ensign deceived the government at approximately 20% of its facilities, potentially facing multi-billion dollar liabilities, which led to a decline in the company's stock price.
  • Law Firm Background: Robbins Geller is a leading law firm in securities fraud and shareholder rights litigation, recovering over $916 million for investors in 2025 alone, and a total of $8.4 billion over the past five years, showcasing its strength in securities class action recoveries.
  • Industry Impact: The investigation and the report could have significant negative implications for Ensign Group's market reputation and stock price, prompting investors to closely monitor developments to assess potential losses.
NASDAQ.COM
8.5
07-03NASDAQ.COM
Ensign Group Acquires Texas Nursing Facilities to Expand Operations
  • Market Expansion: Ensign Group completed the acquisition of two nursing facilities in Texas on July 1, 2026, adding 250 licensed beds and expanding its network to 398 healthcare operations, thereby solidifying its position in a rapidly growing market.
  • Enhanced Financial Flexibility: The transaction was executed by its real estate subsidiary, Standard Bearer Healthcare REIT, which maintains the independence of real estate assets, enhancing financial flexibility and operational control to support long-term growth.
  • Return on Investment: Ensign's return on invested capital (ROIC) stands at 8.12%, significantly above the industry average of 3.05%, demonstrating the effectiveness of its acquisition strategy and is expected to further drive profitability.
  • Strategic Alignment: This acquisition aligns with Ensign's long-term expansion strategy, leveraging a decentralized operating model to improve care quality and occupancy rates, which is anticipated to create sustained value for shareholders.
Globenewswire
7.0
07-03Globenewswire
Ensign Group Under Investigation for Securities Fraud
  • Stock Drop Reasons: Ensign Group's stock fell 8.2% on June 8, 2026, from $170.30 to $156.42 per share due to allegations from Hunterbrook Capital regarding serious care quality failures, indicating deep investor concerns about the company's profit model.
  • Regulatory Compliance Issues: A report from Muddy Waters Research claims that Ensign misrepresents compliance by 'renting' nursing home administrator licenses, which could significantly impact profitability and exacerbate market unease about its future.
  • Legal Options: Bleichmar Fonti & Auld LLP is investigating whether Ensign misled investors and encourages affected investors to submit information to explore legal options, indicating potential risks of class action lawsuits against the company.
  • Industry Impact: As a healthcare services company heavily reliant on Medicare and Medicaid reimbursements, Ensign's transparency and compliance issues may trigger broader scrutiny across the industry, affecting overall investor confidence in the nursing sector.
Wall Street analysts forecast ENSG stock price to rise
4 Analyst Rating
Wall Street analysts forecast ENSG stock price to rise
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
200.00
Averages
209.00
High
220.00
Current: 0.000
sliders
Low
200.00
Averages
209.00
High
220.00
RBC Capital
Outperform
maintain
$206 -> $222
AI Analysis
2026-02-09
Reason
RBC Capital
Price Target
$206 -> $222
AI Analysis
2026-02-09
maintain
Outperform
Reason
RBC Capital raised the firm's price target on Ensign Group to $222 from $206 and keeps an Outperform rating on the shares after its Q4 earnings beat. The company exhibited consistent operational momentum supported by improvements in same-store and transitioning facility metrics, as well as strong acquisition growth, the analyst tells investors in a research note.
UBS
Buy
maintain
$220 -> $230
2026-02-06
Reason
UBS
Price Target
$220 -> $230
2026-02-06
maintain
Buy
Reason
UBS raised the firm's price target on Ensign Group to $230 from $220 and keeps a Buy rating on the shares. Fiscal 2026 should see continued occupancy gains and acquisition activity, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ENSG
Unlock Now

Valuation Metrics

The current forward P/E ratio for Ensign Group, Inc (ENSG.O) is 22.27, compared to its 5-year average forward P/E of 21.40. For a more detailed relative valuation and DCF analysis to assess Ensign Group, Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
21.40
Current PE
22.27
Overvalued PE
23.77
Undervalued PE
19.04

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
16.33
Current EV/EBITDA
16.73
Overvalued EV/EBITDA
18.53
Undervalued EV/EBITDA
14.14

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.57
Current PS
1.52
Overvalued PS
1.75
Undervalued PS
1.40

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

best stock to buy today
Intellectia · 40 candidates
Market Cap: >= 5.00BRevenue Ttm: >= 500.00MPrice: $5.00 - $400.00Quarter Revenue Yoy Growth: >= 0.0%Analyst Consensus: Strong Buy, Moderate BuyEps Ttm: >= 0.000Quarter Eps Yoy Growth: >= 0.0%Pe Ttm: 8 - 40List Exchange: XNYS, XNAS, XASEReturn On Equity: >= 8.0%Target Price Upside Potential: MoreAbovePrice, AbovePriceMoving Average Relationship: PriceAboveMA20, PriceAboveMA200Quarter Price Change Pct: >= $5.00Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
AZN logo
AZN
AstraZeneca PLC
284.42B
PLXS logo
PLXS
Plexus Corp
5.36B
DRS logo
DRS
Leonardo DRS Inc
12.37B
USFD logo
USFD
US Foods Holding Corp
20.31B
RPRX logo
RPRX
Royalty Pharma PLC
27.08B
FCFS logo
FCFS
Firstcash Holdings Inc
8.45B
What stocks should I pick this month
Intellectia · 23 candidates
Market Cap: >= 10.00BRegion: USRevenue 5yr Cagr: >= 12List Exchange: XNYS, XNAS, XASEReturn On Equity: >= 15.0%Moving Average Relationship: PriceAboveMA200One Month Rise Prob: >= 70
Ticker
Name
Market Cap$
top bottom
DAL logo
DAL
Delta Air Lines Inc
45.76B
GOOG logo
GOOG
Alphabet Inc
3.94T
HEI logo
HEI
HEICO Corp
45.01B
VRTX logo
VRTX
Vertex Pharmaceuticals Inc
117.76B
NXT logo
NXT
Nextpower Inc
16.70B
EWBC logo
EWBC
East West Bancorp Inc
16.29B
what stocks will
Intellectia · 3459 candidates
Market Cap: >= 100.00MPrice: $1.00 - $200.00Monthly Average Dollar Volume: >= 100,000
Ticker
Name
Market Cap$
top bottom
KELYB logo
KELYB
Kelly Services Inc
510.65M
PSNY logo
PSNY
Polestar Automotive Holding UK PLC
1.21B
PAHC logo
PAHC
Phibro Animal Health Corp
1.66B
FORM logo
FORM
FormFactor Inc
5.43B
LBRX logo
LBRX
LB Pharmaceuticals Inc
526.22M
ENSG logo
ENSG
Ensign Group Inc
10.05B
find similar stocks of hims and hers
Intellectia · 208 candidates
Market Cap: 300.00M - 15.00BPs Ratio: <= 15.00Is Optionable: TrueAnnual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
GH logo
GH
Guardant Health Inc
14.98B
ICLR logo
ICLR
ICON PLC
14.12B
PEN logo
PEN
Penumbra Inc
14.03B
SOLV logo
SOLV
Solventum Corp
13.94B
SNN logo
SNN
Smith & Nephew PLC
13.91B
NBIX logo
NBIX
Neurocrine Biosciences Inc
13.50B
Top Biotechnology/Health Tech
Intellectia · 82 candidates
Weekly Average Turnover: >= 1,000,000Year Price Change Pct: >= $10.00Annual Eps Yoy Growth: >= 10.0%Annual Revenue Yoy Growth: >= 10.0%
Ticker
Name
Market Cap$
top bottom
LLY logo
LLY
Eli Lilly and Co
1.02T
AZN logo
AZN
AstraZeneca PLC
280.73B
NVS logo
NVS
Novartis AG
278.44B
MCK logo
MCK
McKesson Corp
101.61B
ARGX logo
ARGX
argenx SE
50.52B
ALNY logo
ALNY
Alnylam Pharmaceuticals Inc
48.28B

Whales Holding ENSG

H
Hood River Capital Management LLC
Holding
ENSG
+19.09%
3M Return
C
Clark Capital Management Group Inc
Holding
ENSG
+11.43%
3M Return
O
Oak Ridge Investments, LLC
Holding
ENSG
+10.52%
3M Return
B
Baillie Gifford
Holding
ENSG
+7.86%
3M Return
S
Segall Bryant & Hamill, LLC
Holding
ENSG
+7.33%
3M Return
P
Paradigm Capital Management, Inc.
Holding
ENSG
+6.62%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Ensign Group, Inc (ENSG) stock price today?

The current price of ENSG is 170.87 USD — it has increased 2.42

What is Ensign Group, Inc (ENSG)'s business?

The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at approximately 396 healthcare facilities in Alabama, Alaska, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. The Company's healthcare facilities include over 48 senior living operations across 17 states. The Company's segments include skilled services and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment consists of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. The Company's subsidiaries, including Standard Bearer, own approximately 181 real estate assets.

What is the price predicton of ENSG Stock?

Wall Street analysts forecast ENSG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENSG is209.00 USD with a low forecast of 200.00 USD and a high forecast of 220.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Ensign Group, Inc (ENSG)'s revenue for the last quarter?

Ensign Group, Inc revenue for the last quarter amounts to 1.39B USD, increased 18.43

What is Ensign Group, Inc (ENSG)'s earnings per share (EPS) for the last quarter?

Ensign Group, Inc. EPS for the last quarter amounts to 1.67 USD, increased 21.90

How many employees does Ensign Group, Inc (ENSG). have?

Ensign Group, Inc (ENSG) has 46000 emplpoyees as of July 08 2026.

What is Ensign Group, Inc (ENSG) market cap?

Today ENSG has the market capitalization of 9.99B USD.